The study showed that IL-18 (rs1946518) and NF-κB-94 ins/del (rs28362491) gene polymorphisms contributed to a significantly increased risk for B-cell NHL (p < 0.0001 and p = 0.0029, respectively). The gene discussed is IL18; the disease is B-cell non-Hodgkin lymphoma.